NextGen Biomed – Innovative Peptide Manufacturing Methods That Scale

Joseph Denby, Senior Manager of Business Development at CPC Scientific, presented a case study on sustainable SPPS process design at NextGen Biomed 2026 in London, UK.

Rising peptide demand, fueled by strong GLP-1 momentum, is driving the need for scalable production that supports commercial timelines. Solid-phase peptide synthesis (SPPS) is essential, yet its waste intensity makes process efficiency and sustainability a key focus for CDMOs. This case study presents three key SPPS process innovations that supported multi-kilogram delivery of a pharmaceutically-relevant polypeptide on a challenging timeline, while reducing environmental impact and production costs for the client.